Orbimed Advisors LLC Monte Rosa Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

  • $3.69 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$6.71 - $9.72 $604,477 - $875,635
-90,086 Reduced 76.7%
27,369 $208,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $842,152 - $1.43 Million
117,455 New
117,455 $960,000
Q3 2021

Nov 15, 2021
SELL
$18.59 - $42.21 $6.51 Million - $14.8 Million
-350,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.86 - $22.7 $6.6 Million - $7.95 Million
350,000 New
350,000 $7.95 Million

Others Institutions Holding GLUE

# of Institutions
107
Shares Held
53.8M
Call Options Held
276K
Put Options Held
15.9K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $283M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email